Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization

Clinical trial NCT06435845 · TERMINATED

Trial details

NCT number: NCT06435845
Sponsor: Rallybio
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Fetal and Neonatal Alloimmune Thrombocytopenia

Start date: 2024-11-21
Primary completion: 2025-10-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.